Osaka, Japan

Hiroaki Nomura

This inventor holds 34 USPTO granted patents, primarily in Pyrimidine Compounds. Top assignees: Takeda Chemical Industries, Inc., Eisai Company, Limited. Active years: 1976-1997.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 9

Forward Citations = 267(Granted Patents)


Location History:

  • Osaka, JA (1976)
  • Takatsuki, JA (1977)
  • Mino, JA (1977)
  • Takstsuki, JP (1984)
  • Takatsuki, JP (1978 - 1991)
  • Osaka, JP (1979 - 1993)
  • Ibaraki, JP (1992 - 1997)

Company Filing History:


Years Active: 1976-1997

Loading Chart...
Areas of Expertise:
Pyrimidine Derivatives
Lipid Compounds
Cephalosporins
Antifungal Agents
Glycerol Derivatives
Phospholipids
Carboxylic Acids
Nitrogen Compounds
Sulfur Compounds
Fused Pyrimidines
Anti-Protozoan
Ketoalkylphospholipids
34 patents (USPTO):Explore Patents

Title: The Innovative Mind of Hiroaki Nomura

Introduction: Hiroaki Nomura is a visionary inventor hailing from Osaka, Japan, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Hiroaki Nomura holds several patents in the areas of robotics, artificial intelligence, and renewable energy technologies, showcasing his versatility and forward-thinking approach to problem-solving.

Career Highlights: With a career spanning over two decades, Nomura has worked with leading tech companies in Japan, spearheading research and development projects that have led to significant advancements in various industries.

Collaborations: Throughout his career, Hiroaki Nomura has collaborated with top researchers, engineers, and scientists both locally and internationally, fostering a culture of innovation and knowledge exchange.

Conclusion: Hiroaki Nomura's relentless pursuit of innovation and his passion for pushing the boundaries of technology make him a true pioneer in the world of inventions. His work continues to inspire the next generation of inventors and innovators worldwide.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…